|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Stanley T. CrookePublisher: Taylor & Francis Inc Imprint: CRC Press Inc Edition: 2nd edition Dimensions: Width: 17.80cm , Height: 5.10cm , Length: 25.40cm Weight: 1.730kg ISBN: 9780849387968ISBN 10: 0849387965 Pages: 856 Publication Date: 25 July 2007 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction, The Basics of Oligonucleotide-Based Therapeutics, Hybridization-Based Drugs: Basic Properties 2_-O-Methoxyethyl Oligonucleotides, Hybridization-Based Drugs: Basic Properties Duplex RNA Drugs, Other Chemical Classes of Drugs, Therapeutic Applications, IndexReviewsThis book gives a nearly complete overview of the current state-of-the-art oligonucleotide drugs. ! provides valuable insights into the great opportunities that are presented by this technology. --Dr. Kees Fluiter, The University of Amsterdam, in ChemMedChem, Vol. 4, 2009 This edition is a cutting edge document including up-to-date cited references and a variety of compelling clinical case studies, and it of course retains the superb basic principles and background to antisense drug technologies featured in the first edition. --Gary Evans, Industrial Research Ltd., in Journal of Medicinal Chemistry, 2008, Vol. 51, No. 5 This book gives a nearly complete overview of the current state-of-the-art oligonucleotide drugs. ! provides valuable insights into the great opportunities that are presented by this technology. --Dr. Kees Fluiter, The University of Amsterdam, in ChemMedChem, Vol. 4, 2009 This edition is a cutting edge document including up-to-date cited references and a variety of compelling clinical case studies, and it of course retains the superb basic principles and background to antisense drug technologies featured in the first edition. --Gary Evans, Industrial Research Ltd., in Journal of Medicinal Chemistry, 2008, Vol. 51, No. 5 Author InformationStanley T. Crooke Tab Content 6Author Website:Countries AvailableAll regions |